GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Oncology/CT Use and Future Cancer Risk
175

CT Use and Future Cancer Risk

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated August 1, 2025

The rising use of CT (computed tomography) scans has sparked concerns about its potential long-term impact on cancer risk, as highlighted by a recent modeling study. Below is a detailed analysis of the findings and their implications:

Key Findings:

  1. CT Scan Usage in 2023:
  • In the U.S., approximately 62 million patients underwent nearly 93 million CT scans in 2023 alone.
  • This marks a significant reliance on CT imaging for diagnostic and medical purposes.
  1. Projected Cancer Cases:
  • Researchers estimate that the radiation exposure from this level of CT use could result in about 103,000 future cancer cases.
  • These cases could account for up to 5% of all annual cancer diagnoses, a figure comparable to cancer risks associated with alcohol consumption or excess body weight.
  1. Age and Type of CT Scans:
  • Adults: Abdomen and pelvis CT scans contributed the most to the projected cancer cases.
  • Children: Head CT scans were the largest contributor to projected cancers in this group.
  • Highest Risk Per Scan: Children under 1 year of age face the highest risk per individual scan due to their greater sensitivity to radiation.
  • Largest Number of Cases Overall: Older adults had the highest number of projected cancer cases, primarily because they undergo CT scans more frequently.
  1. Cancer Types Linked to CT Radiation:
  • Adults: Lung, colon, bladder cancers, and leukemia were the most commonly linked cancers.
  • Children: Thyroid, lung, and breast cancers were the most frequently associated with CT scan radiation.
  1. Lifetime Risk Increase:
  • The overall lifetime risk of developing cancer increases slightly due to CT scan radiation exposure — from about 50% to 52.5%.

Implications:

  • Balancing Risks and Benefits:

  • While there is a small increase in lifetime cancer risk, experts emphasize that CT scans are often essential and life-saving tools in medical diagnosis and treatment.

  • The diagnostic benefits of CT imaging generally outweigh the small added cancer risk, especially in urgent or critical cases.

  • Recommendations for Safer Use:

  • Reducing Unnecessary Imaging: Avoiding CT scans that are not medically necessary can help lower overall radiation exposure.

  • Minimizing Radiation Dose: Using the lowest radiation dose possible for effective imaging can reduce long-term risks.

  • Special Considerations for Children: Pediatric patients, especially infants, should be given extra care in minimizing radiation exposure due to their higher sensitivity.

Conclusion:

CT scans are indispensable tools in modern medicine, but their increasing use raises valid concerns about long-term cancer risks. The study underscores the need for judicious use of CT imaging, particularly in vulnerable populations such as children and frequent users like older adults. By optimizing scanning practices and reducing unnecessary exposure, healthcare providers can continue to maximize the diagnostic benefits of CT scans while minimizing potential risks.

Related Q&A

176

Four Key Genes Linked to Worse Gastric Cancer Outcomes

The four key genes linked to worse gastric cancer outcomes, as identified by new research from Brazil, are BRCA2, CDH1, RHOA, and TP53. Here’s a detailed breakdown of...

177

Catching Gastric Cancer early

Catching gastric cancer early is critically important for improving survival outcomes, especially given the poor prognosis associated with late-stage diagnosis. Early detection involves a structured, multidisciplinary approach that...

178

ATOMIC Trial – PD-L1 pulse FOLFOX as adjuvant in CRC

The ATOMIC trial evaluated the efficacy of combining the PD-L1 inhibitor atezolizumab with standard adjuvant chemotherapy (FOLFOX) in patients with stage III colon cancer that is mismatch repair-deficient...

179

Age and Oxaliplatin in CRC chemotherapeutic regime

The use of oxaliplatin in chemotherapy for colorectal cancer (CRC) varies in effectiveness depending on the stage of the disease and the age of the patient. Here's a...

01

Early-Onset Colorectal Cancer Shows a Distinct Molecular Profile: ESMO GI Oncology |September 2026

Introduction: Early-onset colorectal cancer (EOCRC) is rising globally and increasingly appears to be biologically distinct from conventional later-onset CRC. This large clinicogenomic analysis evaluated 6,762 tumors across four...

02

Adjuvant Imatinib in GIST- Who Should Receive It, and for How Long?: ESMO Gastrointestinal Oncology | August 2026

Introduction: Adjuvant imatinib has clearly improved recurrence-free survival after complete resection of high-risk gastrointestinal stromal tumors (GISTs). However, important questions remain regarding who truly benefits, optimal treatment duration,...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer